One risky claim can trigger an FDA warning letter, an FTC investigation, or a State Medical Board complaint.

Catch risky marketing claims before a regulator does.

AI reviews your website's public marketing pages — plus any social posts, emails, or ads you submit — against seven regulatory frameworks: FDA, FTC, HIPAA, ADA, State Medical Board, weight-loss, and device advertising rules. Built for med spas, aesthetic practices, regenerative medicine, plastic surgery, dermatology, IV therapy, and weight-loss clinics.

Your compliance score in about a minute. Free — no credit card required.

Reviews against : FDA marketing guidance · FTC advertising standards · State Medical Board rules · HIPAA marketing rules

We scanned 27 practices like yours last week.

Med spa and aesthetic websites across Ohio and Pennsylvania, picked only because they came up in a search for their own city. Nobody asked us to look.

0
came back with nothing to fix
44%
had a Critical finding
41%
had language we mark for a lawyer
23
median findings per practice

Not one of them was trying to break a rule. That's the point — this is what ordinary aesthetic marketing looks like when someone finally reads it against the rulebook.

See where your site stands — free

Just over a minute on why this matters

The short version: the sentence that causes a problem is almost never something you wrote this week, and nobody reviews a practice website on a schedule. Watch it, or skip it and scan your site instead — that takes about a minute either way.

Scan your site — free

Nobody audits your marketing on a schedule

It gets read once, by one person, for one reason.

One patient complaint

A result didn't match what the website promised. The complaint goes to the state board — and the board reads the page the patient read.

One competitor submission

The practice down the road knows exactly what you claim, because they watch your site. Reporting a competitor is free and anonymous.

One routine look

Regulators run sweeps by service category. Nobody is looking for you specifically until the day they're looking at everyone who offers what you offer.

In all three, the trigger is a sentence that has been on your site for years — not something you did this week. What it costs when that happens →

How it works

A marketing manager can understand it in 30 seconds.

1

Enter your website

Our AI crawls your public marketing pages — services, before & after galleries, testimonials, blog, pricing.

2

AI reviews every word

Each claim is checked against a library of FDA, FTC, HIPAA, ADA, and State Medical Board rules — the same language cited in warning letters.

3

Get a prioritized report

An overall Marketing Risk Score, the exact sentences at risk, why they're a problem, and the appropriate action — a suggested rewrite or escalation to counsel.

What we check

Every public word, scored the way a regulator would read it.

Disease & treatment claims
FDA drug / device language
FTC substantiation rules
Before & after disclaimers
Testimonial compliance
Stem cell & biologics claims
Weight-loss promises
State Medical Board rules
HIPAA marketing exposure
Guarantee & superlative claims
Missing privacy policy
ADA accessibility basics

📸 Check before you publish

Screenshot your last post.
Upload it. Ten seconds.

AI reads the marketing text right out of your image — captions, hashtags, even words overlaid on the photo — and flags risky claims with a suggested fix before a regulator sees them. Works with Instagram posts, ads, stories, and scanned brochures. Or paste copy and upload PDFs, Word docs, and slide decks the same way.

Included with the Digital Audit and every subscription.  See plans →

From risky claim to the right action

We don't just flag problems — the full report recommends what to do about each one: a suggested rewrite, a remediation step, or escalation to counsel.

❌ What you published

"Stem cells regenerate cartilage."

⚠ Why it's a risk

Disease treatment claim · insufficient scientific substantiation · FDA/FTC scrutiny magnet.

✓ Suggested revision

"Stem cell therapies are being investigated for their potential role in regenerative medicine. Individual results vary."